激光手术在儿童皮肤颜色患者:一个系统的审查
相关实验视频
Updated: May 12, 2026

06:06
Apparatus for Harvesting Tissue Microcolumns
Published on: October 25, 2018
5.9K
Shaliz Aflatooni1, Nicholas Chin1, Amberlyn Colina1
1University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Pediatric dermatology
|April 29, 2025
概括
激光手术对于皮肤有色 (菲茨帕特里克皮肤类型IV-VI) 的儿科患者来说是一种安全有效的治疗方法. 早期干预提供了更好的结果,但仔细考虑激光参数对于最佳结果至关重要.
科学领域:
- 皮肤病学 皮肤病学
- 激光手术 激光手术是一种激光手术.
- 儿科医学 儿科医学
背景情况:
- 治疗皮肤有色皮肤的儿科患者的皮肤疾病,由于黑色素对激光能量吸收的影响,存在独特的挑战.
- 较深色皮肤类型 (菲茨帕特里克皮肤类型IV-VI) 的较高黑色素含量可以降低激光的有效性并增加不良事件风险.
研究的目的:
- 系统地审查激光治疗皮肤病症的疗效和安全性,用于菲茨帕特里克皮肤类型IV-VI的儿科患者.
- 在这个特定的患者群体中分析激光参数,治疗结果和潜在的副作用.
主要方法:
- 对23项涉及164名患有菲茨帕特里克皮肤类型IV-VI的儿科患者 (1个月至17岁) 的研究进行了系统审查.
- 纳入标准涉及各种研究设计,评估皮肤病激光治疗.
主要成果:
- 激光手术被证明是患有菲茨帕特里克皮肤类型IV-VI的儿童各种皮肤病的优秀治疗选择.
- 早期激光治疗皮肤有色的儿童可以导致改善的清除和更好的临床结果.
- 成功的结果需要仔细选择激光参数,根据个体患者和所需的临床结果量身定制.
结论:
- 皮肤有色的儿科患者不应被排除在激光手术之外.
- 当使用适当的参数时,激光手术在这个人群中是安全有效的.
- 进一步研究优化激光参数用于儿科患者不同肤色的皮肤颜色是有必要的.
相关概念视频
Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

